Recent studies showed that MG injection of Sprague–Dawley rats may cause glucose intolerance, reduce the insulin-stimulated glucose uptake in adipose tissue, and result in pancreatic dysfunction and that oral administration of MG at 300 mg/kg/day may induce inflammation in the pancreatic β-cells [5,10,20]. The gene discussed is INS; the disease is myasthenia gravis.